HK1214503A1 - 檸檬酸鐵在治療慢性腎臟疾病患者中的應用 - Google Patents
檸檬酸鐵在治療慢性腎臟疾病患者中的應用Info
- Publication number
- HK1214503A1 HK1214503A1 HK16102352.0A HK16102352A HK1214503A1 HK 1214503 A1 HK1214503 A1 HK 1214503A1 HK 16102352 A HK16102352 A HK 16102352A HK 1214503 A1 HK1214503 A1 HK 1214503A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- kidney disease
- chronic kidney
- disease patients
- ferric citrate
- Prior art date
Links
- 208000020832 chronic kidney disease Diseases 0.000 title 1
- 229960002413 ferric citrate Drugs 0.000 title 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261662565P | 2012-06-21 | 2012-06-21 | |
US201361757229P | 2013-01-28 | 2013-01-28 | |
US201361800618P | 2013-03-15 | 2013-03-15 | |
US201361801050P | 2013-03-15 | 2013-03-15 | |
PCT/US2013/047134 WO2013192565A2 (en) | 2012-06-21 | 2013-06-21 | Use of ferric citrate in the treatment of chronic kidney disease patients |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1214503A1 true HK1214503A1 (zh) | 2016-07-29 |
Family
ID=49769729
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15110673.6A HK1210013A1 (zh) | 2012-06-21 | 2015-10-28 | 檸檬酸鉄在治療慢性腎臟疾病患者中的應用 |
HK16102352.0A HK1214503A1 (zh) | 2012-06-21 | 2016-03-01 | 檸檬酸鐵在治療慢性腎臟疾病患者中的應用 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15110673.6A HK1210013A1 (zh) | 2012-06-21 | 2015-10-28 | 檸檬酸鉄在治療慢性腎臟疾病患者中的應用 |
Country Status (17)
Country | Link |
---|---|
US (3) | US20130345303A1 (zh) |
EP (3) | EP2863906B1 (zh) |
JP (4) | JP2015535209A (zh) |
KR (2) | KR20200103855A (zh) |
CN (2) | CN113244209A (zh) |
AU (2) | AU2013278000A1 (zh) |
BR (1) | BR112014032049A2 (zh) |
CA (1) | CA2876982A1 (zh) |
DK (1) | DK3730136T3 (zh) |
EA (1) | EA201590062A1 (zh) |
ES (2) | ES2970050T3 (zh) |
HK (2) | HK1210013A1 (zh) |
IL (1) | IL236356A0 (zh) |
MX (1) | MX2014015615A (zh) |
PL (1) | PL3730136T3 (zh) |
SG (2) | SG10201805177PA (zh) |
WO (1) | WO2013192565A2 (zh) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102573807A (zh) | 2009-07-21 | 2012-07-11 | 凯克斯生物制药公司 | 柠檬酸铁剂型 |
TWI653043B (zh) * | 2012-12-20 | 2019-03-11 | 瑞士商伊蘭科動物健康公司 | 新用途 |
DK3578185T3 (da) | 2013-06-05 | 2020-11-02 | Tricida Inc | Protonbindende polymerer til oral indgivelse |
EP2856941B1 (en) * | 2013-10-01 | 2020-11-25 | Fresenius Medical Care Deutschland GmbH | Method and apparatuses for determining a patient's daily loss of iron |
JP2016535780A (ja) * | 2013-11-04 | 2016-11-17 | ケリク バイオファーマシューティカルス, インコーポレーテッド | 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄 |
WO2015110968A1 (en) * | 2014-01-23 | 2015-07-30 | Lupin Limited | Pharmaceutical grade ferric citrate and method for its production |
EP3157516A4 (en) | 2014-06-22 | 2017-12-13 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
EP3593808B1 (en) | 2014-12-10 | 2020-12-09 | Tricida Inc. | Proton-binding polymers for oral administration |
KR20170123664A (ko) * | 2015-03-04 | 2017-11-08 | 케릭스 바이오파마슈티컬스 인코포레이티드 | 철-결핍성 빈혈의 치료에서 구연산철의 용도 |
CN104688706B (zh) * | 2015-04-01 | 2017-07-14 | 成都欣捷高新技术开发有限公司 | 一种高载药量、快速溶出的枸橼酸铁组合物及其制备方法 |
WO2016162794A1 (en) * | 2015-04-08 | 2016-10-13 | Leiutis Pharmaceuticals Pvt Ltd | Pharmaceutical compositions of ferric citrate |
WO2016162888A1 (en) * | 2015-04-09 | 2016-10-13 | Actavis Group Ptc Ehf. | Process for preparing pharmaceutical grade ferric citrate |
WO2017193024A1 (en) | 2016-05-06 | 2017-11-09 | Tricida, Inc. | Hcl-binding compositions for and method of treating acid-base disorders |
US20210085711A1 (en) | 2017-09-19 | 2021-03-25 | Japan Tobacco Inc. | Use of ferric citrate in prevention and/or treatment of iron-deficiency anemia in hypermenorrhea patient and/or patient suffering from hypermenorrhea-associated gynecologic disease |
US11266684B2 (en) | 2017-11-03 | 2022-03-08 | Tricida, Inc. | Compositions for and method of treating acid-base disorders |
WO2019236639A1 (en) * | 2018-06-04 | 2019-12-12 | Tricida, Inc. | Method of treating acid-base disorders |
BR112021008142A2 (pt) * | 2018-10-29 | 2021-08-03 | Pharmacosmos Holding A/S | tratamento de deficiência de ferro com carboximaltose férrica |
WO2022150623A1 (en) | 2021-01-08 | 2022-07-14 | Akebia Therapeutics, Inc. | Compounds and composition for the treatment of anemia |
TW202313072A (zh) | 2021-05-27 | 2023-04-01 | 美商凱立克斯生物製藥股份有限公司 | 檸檬酸鐵之兒科調配物 |
CN115024495B (zh) * | 2022-06-27 | 2024-03-22 | 北京金康普食品科技有限公司 | 改善肾病患者钙磷代谢的营养组合物及其应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998003185A1 (fr) * | 1996-07-19 | 1998-01-29 | Nikken Chemicals Co., Ltd. | Remedes contre l'hyperphosphatemie |
US5753706A (en) * | 1996-12-16 | 1998-05-19 | Hsu; Chen Hsing | Methods for treating renal failure |
TWI335218B (en) | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
US8093423B2 (en) | 2003-02-19 | 2012-01-10 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same |
CN1600302A (zh) * | 2003-09-22 | 2005-03-30 | 宝龄富锦生技股份有限公司 | 含有柠檬酸铁的医药组合物以及药用级柠檬酸铁及其制法和含有药用级柠檬酸铁的膳食营养品 |
US20060134227A1 (en) * | 2004-12-22 | 2006-06-22 | Bortz Jonathan D | Compositions including iron |
CA3050453C (en) | 2005-08-18 | 2021-07-27 | Panion & Bf Biotech Inc. | Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same |
KR20180077337A (ko) * | 2006-01-06 | 2018-07-06 | 루이트폴드 파머수티컬스, 인코퍼레이티드 | 철을 투여하기 위한 방법 및 조성물 |
HUE028029T2 (en) | 2006-01-30 | 2016-11-28 | Panion & Bf Biotech Inc | A method of treating chronic kidney disease |
CN102573807A (zh) * | 2009-07-21 | 2012-07-11 | 凯克斯生物制药公司 | 柠檬酸铁剂型 |
-
2013
- 2013-06-21 US US13/924,332 patent/US20130345303A1/en not_active Abandoned
- 2013-06-21 MX MX2014015615A patent/MX2014015615A/es unknown
- 2013-06-21 KR KR1020207024260A patent/KR20200103855A/ko not_active IP Right Cessation
- 2013-06-21 DK DK20163104.1T patent/DK3730136T3/da active
- 2013-06-21 CA CA2876982A patent/CA2876982A1/en not_active Abandoned
- 2013-06-21 KR KR1020157001458A patent/KR102150135B1/ko active IP Right Grant
- 2013-06-21 SG SG10201805177PA patent/SG10201805177PA/en unknown
- 2013-06-21 SG SG11201408521WA patent/SG11201408521WA/en unknown
- 2013-06-21 AU AU2013278000A patent/AU2013278000A1/en not_active Abandoned
- 2013-06-21 EP EP13807102.2A patent/EP2863906B1/en active Active
- 2013-06-21 CN CN202110644193.4A patent/CN113244209A/zh active Pending
- 2013-06-21 EA EA201590062A patent/EA201590062A1/ru unknown
- 2013-06-21 WO PCT/US2013/047134 patent/WO2013192565A2/en active Application Filing
- 2013-06-21 EP EP23219273.2A patent/EP4335436A3/en active Pending
- 2013-06-21 ES ES20163104T patent/ES2970050T3/es active Active
- 2013-06-21 EP EP20163104.1A patent/EP3730136B1/en active Active
- 2013-06-21 JP JP2015518623A patent/JP2015535209A/ja active Pending
- 2013-06-21 CN CN201380044271.0A patent/CN104884055A/zh active Pending
- 2013-06-21 ES ES13807102T patent/ES2796254T3/es active Active
- 2013-06-21 PL PL20163104.1T patent/PL3730136T3/pl unknown
- 2013-06-21 BR BR112014032049A patent/BR112014032049A2/pt not_active IP Right Cessation
-
2014
- 2014-04-25 US US14/262,465 patent/US20140234416A1/en not_active Abandoned
- 2014-10-24 US US14/523,656 patent/US20150079168A1/en not_active Abandoned
- 2014-12-18 IL IL236356A patent/IL236356A0/en unknown
-
2015
- 2015-10-28 HK HK15110673.6A patent/HK1210013A1/zh unknown
-
2016
- 2016-03-01 HK HK16102352.0A patent/HK1214503A1/zh unknown
-
2018
- 2018-04-10 JP JP2018075243A patent/JP2018138562A/ja active Pending
- 2018-05-08 AU AU2018203205A patent/AU2018203205B2/en not_active Ceased
-
2020
- 2020-02-25 JP JP2020029756A patent/JP2020100638A/ja active Pending
-
2022
- 2022-02-10 JP JP2022019167A patent/JP2022070945A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1214503A1 (zh) | 檸檬酸鐵在治療慢性腎臟疾病患者中的應用 | |
IL285843A (en) | Ibrutinib for use in the treatment of graft-versus-host disease | |
HK1221178A1 (zh) | 卡博替尼劑型及其在癌症治療中的使用 | |
HK1217088A1 (zh) | 微泡在醫學疾病和病况的診斷、預後和治療中的用途 | |
EP2890440A4 (en) | DEVICES AND METHOD FOR THE TREATMENT OF VASCULAR DISEASES | |
GB2495841B (en) | Phytocannabinoids for use in the treatment of breast cancer | |
GB201115711D0 (en) | Phyto-cannabinoids for use in the treatment of cancer | |
GB201314512D0 (en) | Dual Haemodialysis and Haemodiafiltration blood treatment device | |
IL239007A0 (en) | Use of Aribolin to treat breast cancer | |
IL229474A0 (en) | Cannabinoids for use in the treatment of neuropathic pain | |
HK1223031A1 (zh) | 用於降低慢性腎病患者的心力衰竭的枸櫞酸鐵 | |
EP2875158A4 (en) | USE OF MICROVESICLES IN THE DIAGNOSIS, FORECAST AND TREATMENT OF DISEASES AND MEDICAL SUDDEN | |
HUS2000020I1 (hu) | Ciklezonid a légúti betegségek kezelésére lovaknál | |
HK1212255A1 (zh) | 青蒿素和其衍生物用於治療腎病 | |
HK1202473A1 (zh) | 用於在病人的血管系統中的醫療用途的流體注射系統 | |
SG11201601490XA (en) | Risk markers for cardiovascular disease in patients with chronic kidney disease | |
GB2515440B (en) | Vesicular Formulations for use in the treatment of Rosacea | |
LT2872176T (lt) | Karboranilporfirinai, skirti naudoti vėžio gydymui | |
EP2744786A4 (en) | SUBSTITUTED 2-IMIDAZOLIDINONE AND 2-IMIDAZOLONE AND THEIR USE IN THE TREATMENT OF CANCER | |
HK1198128A1 (zh) | 牛蒡子苷元在製備治療消化道潰瘍性疾病藥物中的應用 | |
RS57172B1 (sr) | Preparati za upotrebu u lečenju dislipidemije kod hroničnog oboljenja bubrega | |
EP2928461A4 (en) | TREATMENT FOR CHRONIC KIDNEY DISEASE |